Morgan Stanley’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $107M | Buy |
1,018,222
+139,198
| +16% | +$12.3M | 0.01% | 1379 |
|
|
2025
Q4 | $76.8M | Buy |
879,024
+110,665
| +14% | +$9.06M | ﹤0.01% | 1690 |
|
|
2025
Q3 | $51M | Sell |
768,359
-100,604
| -12% | -$5.72M | ﹤0.01% | 1990 |
|
|
2025
Q2 | $48M | Buy |
868,963
+371,858
| +75% | +$17.8M | ﹤0.01% | 1972 |
|
|
2025
Q1 | $24M | Sell |
497,105
-43,210
| -8% | -$1.81M | ﹤0.01% | 2508 |
|
|
2024
Q4 | $20.9M | Sell |
540,315
-88,308
| -14% | -$3.85M | ﹤0.01% | 2705 |
|
|
2024
Q3 | $28.3M | Buy |
628,623
+283,330
| +82% | +$11.4M | ﹤0.01% | 2440 |
|
|
2024
Q2 | $12M | Sell |
345,293
-1,534,585
| -82% | -$44.9M | ﹤0.01% | 3175 |
|
|
2024
Q1 | $54.4M | Sell |
1,879,878
-503,796
| -21% | -$13.7M | ﹤0.01% | 1684 |
|
|
2023
Q4 | $54.7M | Buy |
2,383,674
+1,954,670
| +456% | +$34.2M | ﹤0.01% | 2351 |
|
|
2023
Q3 | $7.16M | Sell |
429,004
-149,017
| -26% | -$2.89M | ﹤0.01% | 3425 |
|
|
2023
Q2 | $16M | Sell |
578,021
-992,489
| -63% | -$24.8M | ﹤0.01% | 2704 |
|
|
2023
Q1 | $36.1M | Sell |
1,570,510
-868,007
| -36% | -$14.6M | ﹤0.01% | 1849 |
|
|
2022
Q4 | $26.6M | Buy |
2,438,517
+210,942
| +9% | +$1.78M | ﹤0.01% | 2052 |
|
|
2022
Q3 | $18.8M | Buy |
2,227,575
+451,123
| +25% | +$4.27M | ﹤0.01% | 2253 |
|
|
2022
Q2 | $14.1M | Buy |
1,776,452
+439,349
| +33% | +$5.31M | ﹤0.01% | 2681 |
|
|
2022
Q1 | $31.7M | Buy |
1,337,103
+1,229,687
| +1,145% | +$34.6M | ﹤0.01% | 1658 |
|
|
2021
Q4 | $3.67M | Sell |
107,416
-366,899
| -77% | -$11.6M | ﹤0.01% | 4046 |
|
|
2021
Q3 | $8.4M | Buy |
474,315
+404,485
| +579% | +$17.2M | ﹤0.01% | 3094 |
|
|
2021
Q2 | $3.13M | Buy |
69,830
+65,107
| +1,379% | +$2.15M | ﹤0.01% | 4242 |
|
|
2021
Q1 | $123K | Sell |
4,723
-28,766
| -86% | -$728K | ﹤0.01% | 5904 |
|
|
2020
Q4 | $675K | Buy |
33,489
+25,544
| +322% | +$550K | ﹤0.01% | 4893 |
|
|
2020
Q3 | $156K | Sell |
7,945
-2,833
| -26% | -$53.2K | ﹤0.01% | 5224 |
|
|
2020
Q2 | $190K | Buy |
10,778
+9,415
| +691% | +$118K | ﹤0.01% | 5096 |
|
|
2020
Q1 | $10K | Sell |
1,363
-31,966
| -96% | -$240K | ﹤0.01% | 6019 |
|
|
2019
Q4 | $235K | Sell |
33,329
-88,674
| -73% | -$881K | ﹤0.01% | 5350 |
|
|
2019
Q3 | $1.47M | Buy |
122,003
+121,347
| +18,498% | +$1.53M | ﹤0.01% | 4050 |
|
|
2019
Q2 | $8K | Sell |
656
-3,831
| -85% | -$42.4K | ﹤0.01% | 6196 |
|
|
2019
Q1 | $57K | Buy |
4,487
+54
| +1% | +$477 | ﹤0.01% | 5613 |
|
|
2018
Q4 | $30K | Sell |
4,433
-18,204
| -80% | -$144K | ﹤0.01% | 5919 |
|
|
2018
Q3 | $233K | Sell |
22,637
-23,043
| -50% | -$198K | ﹤0.01% | 5381 |
|
|
2018
Q2 | $308K | Buy |
45,680
+17,503
| +62% | +$134K | ﹤0.01% | 5364 |
|
|
2018
Q1 | $242K | Buy |
28,177
+593
| +2% | +$11.2K | ﹤0.01% | 5393 |
|
|
2017
Q4 | $574K | Buy |
27,584
+8,303
| +43% | +$147K | ﹤0.01% | 4892 |
|
|
2017
Q3 | $341K | Buy |
19,281
+10,904
| +130% | +$151K | ﹤0.01% | 5095 |
|
|
2017
Q2 | $95K | Sell |
8,377
-1,524
| -15% | -$16.3K | ﹤0.01% | 5655 |
|
|
2017
Q1 | $127K | Sell |
9,901
-12,877
| -57% | -$208K | ﹤0.01% | 5511 |
|
|
2016
Q4 | $501K | Buy |
22,778
+22,578
| +11,289% | +$503K | ﹤0.01% | 4929 |
|
|
2016
Q3 | $4K | Buy |
+200
| New | +$2.73K | ﹤0.01% | 6278 |
|
Other funds holding PTGX
FCM
RI
VPM
VCM
JJ